Viewing Study NCT06423807



Ignite Creation Date: 2024-06-16 @ 11:48 AM
Last Modification Date: 2024-10-26 @ 3:30 PM
Study NCT ID: NCT06423807
Status: COMPLETED
Last Update Posted: 2024-05-22
First Post: 2024-05-16

Brief Title: Preoperative Ondansetron Lozenge for Prevention of Post-Spinal Shivering in Caesarean Section
Sponsor: Tanta University
Organization: Tanta University

Study Overview

Official Title: Preoperative Ondansetron Lozenge for Prevention of Post-Spinal Shivering in Caesarean Section A Randomized Controlled Trial
Status: COMPLETED
Status Verified Date: 2024-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The aim of this study is to estimate the role of ondansetron lozenge on prevention of post-spinal shivering in cesarean section
Detailed Description: Spinal anesthesia SA is preferred for cesarean section CS compared with general anesthesiaGA because of several advantages including prevention of the potential risk of GA-related neurotoxicity

Post-spinal shivering PSS could be a provocative factor for postoperative pain and its appropriate treatment prevents non-thermoregulatory tremors Shivering also causes aggravating postoperative pain by stretching of sutures

Ondansetron is a selective antagonist for receptor 5-hydroxytryptamine 3 and is very effective in the prevention and treatment of shivering intra- and post-operation Ondansetron can affect the body temperature and shivering in rats since the balance of nor-epinephrine and 5-hydroxytryptamine 5-HT in the preoptic-anterior hypothalamus controls the temperature set point

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None